Skip to main content
OpenTrials

Clinical trial condition

Epilepsies, Myoclonic

Explore clinical trials studying Epilepsies, Myoclonic. Study availability and eligibility vary by location and protocol.

58 public trials 14 recruiting studies
Refine in advanced search Browse all conditions

Epilepsies, Myoclonic trial results

Recruiting

A Phase 3, Placebo-Controlled Study to Investigate LP352 in Children and Adults With Dravet Syndrome (DS)

NCT06660394

Conditions
Brain Diseases, Central Nervous System Diseases, Dravet Syndrome, +11 more
Locations
  • Arkansas Children's Hospital - PIN Little Rock, Arkansas, United States
  • Children's Hospital Los Angeles - PIN Los Angeles, California, United States
  • David Geffen School of Medicine at UCLA Los Angeles, California, United States
  • The Stanford Division of Child Neurology Palo Alto, California, United States
View all 102 locations
View Trial Details
Recruiting

A Clinical Study to Evaluate the Safety and Efficacy of ETX101 in Infants and Children With SCN1A-Positive Dravet Syndrome

NCT05419492

Conditions
Brain Diseases, Central Nervous System Diseases, Dravet Syndrome, +6 more
Locations
  • UCSF Benioff Children's Hospitals San Francisco, California, United States
  • Colorado Children's Hospital Aurora, Colorado, United States
  • Nicklaus Children's Hospital Miami, Florida, United States
  • Ann & Robert H. Lurie Children's Hospital of Chicago Chicago, Illinois, United States
View all 14 locations
View Trial Details
Recruiting

A Double-blind Study Evaluating the Efficacy, Safety, and Tolerability of Zorevunersen in Patients With Dravet Syndrome

NCT06872125

Conditions
Brain Diseases, Central Nervous System Diseases, Dravet Syndrome, +5 more
Locations
  • Phoenix Children's Hospital Phoenix, Arizona, United States
  • Arkansas Children's Hospital Little Rock, Arkansas, United States
  • Cedars Sinai Medical Center Los Angeles, California, United States
  • Children's Hospital of Orange County Orange, California, United States
View all 58 locations
View Trial Details
Recruiting

A Study of EPX-100 (Clemizole Hydrochloride) in Participants With Dravet Syndrome

NCT04462770

Conditions
Brain Diseases, Central Nervous System Diseases, Dravet Syndrome, +9 more
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • Arkansas Children's Hospital Little Rock, Arkansas, United States
  • Children's Hospital of Los Angeles Los Angeles, California, United States
  • University of California Irvine Orange, California, United States
View all 60 locations
View Trial Details

Related conditions